Affiliation:
1. Office of Biostatistics & Epidemiology Center for Biologics Evaluation and Research US Food and Drug Administration Silver Spring MD USA
Subject
Genetics(clinical),Hematology,General Medicine
Reference30 articles.
1. Advancing the science of patient input throughout the regulatory decision-making process
2. Patient-focused drug development programme takes first steps
3. US Department of Health Human Services.The voice of the patient: A series of reports from FDA's patient‐focused drug development initiative. US Food and Drug Administration. In Public Meeting.2014.http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm368342.htm. Accessed March 8 2019.
4. Medical Device Innovation Consortium.A Framework for Incorporating Information on Patient Preferences Regarding Benefit and Risk into Regulatory Assessment of New Medical Technology.Minneapolis MN:Medical Device Innovation Consortium.2015.
5. Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献